ABT-239
ABT-239 is an H3-receptor inverse agonist developed by Abbott. It has stimulant and nootropic effects, and has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia. ABT-239 is more active at the human H3 receptor than comparable agents such as thioperamide, ciproxifan, and cipralisant.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1360 |
| CAS # | 460746-46-7 |
| Pricing | Customizable size, Inquiry |
| Synonym | ABT-239; ABT 239; ABT239; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C22H22N2O |
| Exact Mass | 330.17321 |
| Molecular Weight | 330.42 |
| Elemental Analysis | C, 79.97; H, 6.71; N, 8.48; O, 4.84 |
| IUPAC/Chemical Name |
|
| InChi Key | KFHYZKCRXNRKRC-MRXNPFEDSA-N |
| InChi Code | InChI=1S/C22H22N2O/c1-16-3-2-11-24(16)12-10-21-14-20-13-19(8-9-22(20)25-21)18-6-4-17(15-23)5-7-18/h4-9,13-14,16H,2-3,10-12H2,1H3/t16-/m1/s1 |
| SMILES Code | N#CC1=CC=C(C2=CC=C(OC(CCN3[C@H](C)CCC3)=C4)C4=C2)C=C1 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |